Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.40
-0.01-0.71%
Last update: Oct 9, 4:00 PM
Dogwood Therapeutics Inc (DWTX) Stock Price, Quote, News & History
DWTXNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Dogwood Therapeutics Inc is a development-stage biopharmaceutical company focused on developing new medicines to treat pain and neuropathy. The pipeline is focused on treating chronic neuropathic pain and neuropathy. The Company operates in one...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Dogwood Therapeutics (NASDAQ:DWTX) through any online brokerage.
Other companies in Dogwood Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Dogwood Therapeutics has a consensus price target of $12.00.
The stock price for Dogwood Therapeutics (NASDAQ: DWTX) is $1.4 last updated October 9, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Dogwood Therapeutics.
Dogwood Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Dogwood Therapeutics.
Dogwood Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
